GIF smart molding 100px

LATEST ISSUE

Fakuma Banner 368x150 2024 Leitmotiv DE

Tags
Shows
15. - 19.
October 2024
Fakuma
Friedrichshafen, 
Germany
19. - 22.
04. - 07.
Have some relevant information to share? Send a message to info@smart-molding.com — we are always happy to discuss!
Логотип сайта
Clearance granted

Clearance granted

News 26.09.2024

Nvision Biomedical Technologies™, San Antonio, Texas (USA) and Invibio Biomaterial Solutions™ (Invibio Ltd, part of Victrex plc, Lancashire, UK), has recently announce that the U.S. Food and Drug Administration (FDA) has granted clearance of the first 3D-Printed PEEK Interbody System made from PEEK-OPTIMA™, a polymer from Invibio Biomaterial Solutions (‘Invibio’) and using the proprietary Bond3D additive manufacturing technology.

Screenshot 1

Nvision interbody system close-up highlights porous PEEK-OPTIMA structure. Image shown is 1.8x zoom, 43x total magnification

The 3D-Printed PEEK Interbody System from Nvision Biomedical Technologies, a San Antonio-based medical device and implant manufacturer, was co-developed with Invibio Biomaterial Solutions. The system consists of Cervical and Anterior Lumbar Interbody Fusion (ALIF) spine devices, each incorporating extensive porous structures that have the potential to promote multi-directional bone ingrowth and improve device fixation, whilst also maintaining PEEK-OPTIMA’s inherent benefits in modulus and imaging.

The use of PEEK-OPTIMA™ - a material that has already been used in over 15 million implants - offers the benefits of mechanical properties closer to those of bone and also superior imaging capability than titanium implants, the latter allowing surgeons to more accurately monitor fusion progression. Nvision’s 3D-Printed PEEK Interbody System is a standout in the field of spinal devices as it is the first to combine PEEK-OPTIMA with the design freedom enabled by the Bond3D additive manufacturing technology to print solid and porous areas for bone ingrowth.

Brian Kieser, CEO of Nvision Biomedical Technologies, commented “Our partnership with Invibio on this project showcases our commitment to pushing the boundaries of medical device innovation”. Kieser continued “This latest FDA clearance builds on a history of successful co-development between Nvision and Invibio, particularly in spine and foot-and-ankle devices. We are thrilled to introduce the 3D-Printed PEEK Cervical and ALIF lines, available in various footprints and lordotic angles, and all incorporating the same porous design features aimed at promoting bone ingrowth.”

Tom Zink, Senior Vice President of Product Development at Nvision Biomedical Technologies, added “We’re constantly looking at new ways to equip surgeons with the opportunity to get the best outcomes for their patients. Leveraging this cutting-edge PEEK additive manufacturing platform through Invibio enables us to take a more innovative approach in the design process and address previous limitations.”

Screenshot 2

Bond3D Additive Manufacturing process of Invibio PEEK-OPTIMA used for Nvision Interbody System

Dr. Steven Lee, MD a spine and orthopedic surgeon gave a clinical end-user perspective, stating - “These new interbody devices, conceived from the collaboration of Nvision and Invibio, will allow me to further improve the quality of care and surgical outcomes that I can provide to my patients. PEEK-OPTIMA’s modulus of elasticity helps to prevent subsidence. Its radiolucency allows for the confirmation of the fusion process. The benefit of a printed porous structure that mimics native bone allows for bone growth into the device itself - thereby enhancing the construct stability. These combined new implant characteristics of strength, reduced subsidence, boney ingrowth, and radiolucency will provide clinical benefits to all my patients.”

Nvision and Invibio collaborated in the development of the 3D-printed PEEK Interbody System, with Invibio carrying out development of the PEEK-OPTIMA and Bond3D technology platform, performance testing early in the process, and eventually filing a new master file (MAF) with the FDA to support this and future regulatory submissions.

John Devine, MD of Invibio said “The proprietary BOND3D advanced manufacturing process used in this device is available through Invibio to allow device companies to realise their innovative designs. Being able to access this process is a breakthrough for device companies because it allows much greater design freedom that would not otherwise be possible with conventional manufacturing methods”. Devine continued, “The combination of solid and highly intricate porous PEEK-OPTIMA structures within the Nvision system allows for potential bone ingrowth to achieve fixation while maintaining the inherent benefits of PEEK-OPTIMA for imaging and bone-like modulus.”

Nvision and Invibio remain committed to continuous innovation in the medical device field, with future focus aimed at expanding the applications of 3D printed PEEK technology to meet the growing needs of surgeons and patients worldwide.

EMP25 Plastiks smartmolding 368x90 EN

Our website makes use of cookies to ensure we give you the best experience on our website.
By continuing browsing on our website you give your consent to our use of cookies.